

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.65949425 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.21615758 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.17527701 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.00995701 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 4.93932275 |
| 6 | locomotory exploration behavior (GO:0035641) | 4.90593122 |
| 7 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.86331606 |
| 8 | vocalization behavior (GO:0071625) | 4.82745119 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.81362158 |
| 10 | glutamate secretion (GO:0014047) | 4.71997111 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.55470309 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.54162255 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.51707854 |
| 14 | detection of molecule of bacterial origin (GO:0032490) | 4.50241688 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.47474933 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.47474933 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 4.47474933 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 4.47474933 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 4.47474933 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.47474933 |
| 21 | protein localization to synapse (GO:0035418) | 4.44942596 |
| 22 | cellular extravasation (GO:0045123) | 4.30088430 |
| 23 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.28929673 |
| 24 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.28439764 |
| 25 | neuronal action potential propagation (GO:0019227) | 4.26658735 |
| 26 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.26101753 |
| 27 | activated T cell proliferation (GO:0050798) | 4.25083470 |
| 28 | microglial cell activation (GO:0001774) | 4.24594314 |
| 29 | neuron cell-cell adhesion (GO:0007158) | 4.16585087 |
| 30 | regulation of synaptic vesicle transport (GO:1902803) | 4.13675276 |
| 31 | negative regulation of cell killing (GO:0031342) | 4.13043957 |
| 32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.13043957 |
| 33 | neutrophil mediated immunity (GO:0002446) | 4.10656843 |
| 34 | exploration behavior (GO:0035640) | 3.98052714 |
| 35 | glutamate receptor signaling pathway (GO:0007215) | 3.96118319 |
| 36 | layer formation in cerebral cortex (GO:0021819) | 3.95143059 |
| 37 | neutrophil activation involved in immune response (GO:0002283) | 3.94790295 |
| 38 | neurotransmitter secretion (GO:0007269) | 3.92325831 |
| 39 | detection of other organism (GO:0098543) | 3.91560202 |
| 40 | synaptic transmission, glutamatergic (GO:0035249) | 3.90532202 |
| 41 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.83270498 |
| 42 | regulation of synapse structural plasticity (GO:0051823) | 3.82901307 |
| 43 | macrophage activation involved in immune response (GO:0002281) | 3.82209258 |
| 44 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.80774372 |
| 45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.80638355 |
| 46 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.80509265 |
| 47 | cellular potassium ion homeostasis (GO:0030007) | 3.77667043 |
| 48 | neuron-neuron synaptic transmission (GO:0007270) | 3.77079797 |
| 49 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.74395412 |
| 50 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.74056076 |
| 51 | myeloid leukocyte mediated immunity (GO:0002444) | 3.68118663 |
| 52 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.64845352 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.60700397 |
| 54 | respiratory burst (GO:0045730) | 3.60609260 |
| 55 | detection of external biotic stimulus (GO:0098581) | 3.60109947 |
| 56 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.59035513 |
| 57 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.58003448 |
| 58 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.57032709 |
| 59 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.54896173 |
| 60 | neural tube formation (GO:0001841) | 3.54524683 |
| 61 | membrane depolarization during action potential (GO:0086010) | 3.51810939 |
| 62 | positive regulation of mast cell activation (GO:0033005) | 3.50687329 |
| 63 | gamma-aminobutyric acid transport (GO:0015812) | 3.49751846 |
| 64 | long-term memory (GO:0007616) | 3.49618832 |
| 65 | proline transport (GO:0015824) | 3.46856366 |
| 66 | histone H3-K36 demethylation (GO:0070544) | 3.44075287 |
| 67 | regulation of postsynaptic membrane potential (GO:0060078) | 3.43358822 |
| 68 | macrophage activation (GO:0042116) | 3.43247178 |
| 69 | synaptic vesicle endocytosis (GO:0048488) | 3.42646621 |
| 70 | response to peptidoglycan (GO:0032494) | 3.40189872 |
| 71 | dendritic spine morphogenesis (GO:0060997) | 3.39686686 |
| 72 | positive regulation of synapse maturation (GO:0090129) | 3.38542893 |
| 73 | activation of protein kinase A activity (GO:0034199) | 3.37662122 |
| 74 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.36817839 |
| 75 | sodium ion export (GO:0071436) | 3.34370062 |
| 76 | positive regulation of membrane potential (GO:0045838) | 3.34336161 |
| 77 | neuron recognition (GO:0008038) | 3.31737901 |
| 78 | detection of biotic stimulus (GO:0009595) | 3.30709593 |
| 79 | cell communication by electrical coupling (GO:0010644) | 3.30652292 |
| 80 | neurotransmitter transport (GO:0006836) | 3.26573144 |
| 81 | detection of bacterium (GO:0016045) | 3.25888014 |
| 82 | B cell receptor signaling pathway (GO:0050853) | 3.25026593 |
| 83 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.24814512 |
| 84 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.23113640 |
| 85 | response to host immune response (GO:0052572) | 3.23113640 |
| 86 | regulation of neurotransmitter secretion (GO:0046928) | 3.21998702 |
| 87 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.20478623 |
| 88 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.19589249 |
| 89 | detection of calcium ion (GO:0005513) | 3.18993171 |
| 90 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.16815909 |
| 91 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.16125878 |
| 92 | vesicle transport along microtubule (GO:0047496) | 3.15526564 |
| 93 | transmission of nerve impulse (GO:0019226) | 3.15268675 |
| 94 | membrane depolarization (GO:0051899) | 3.15032594 |
| 95 | regulation of gamma-delta T cell activation (GO:0046643) | 3.14366404 |
| 96 | nuclear pore complex assembly (GO:0051292) | 3.14160719 |
| 97 | presynaptic membrane assembly (GO:0097105) | 3.13186057 |
| 98 | regulation of synaptic plasticity (GO:0048167) | 3.12433044 |
| 99 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.11464068 |
| 100 | nerve growth factor signaling pathway (GO:0038180) | 3.10318732 |
| 101 | * cerebellar Purkinje cell differentiation (GO:0021702) | 3.10272423 |
| 102 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.08790435 |
| 103 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.08747155 |
| 104 | neutrophil activation (GO:0042119) | 3.08735883 |
| 105 | innervation (GO:0060384) | 3.08431661 |
| 106 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.07765458 |
| 107 | dendrite morphogenesis (GO:0048813) | 3.06588362 |
| 108 | regulation of vesicle fusion (GO:0031338) | 3.05990872 |
| 109 | axonal fasciculation (GO:0007413) | 3.04890795 |
| 110 | leukocyte aggregation (GO:0070486) | 3.03929089 |
| 111 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.03737327 |
| 112 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.03549000 |
| 113 | positive regulation of mast cell degranulation (GO:0043306) | 3.01578147 |
| 114 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.01578147 |
| 115 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.98487017 |
| 116 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.98428154 |
| 117 | negative regulation of T cell mediated immunity (GO:0002710) | 2.98252432 |
| 118 | negative regulation of interleukin-12 production (GO:0032695) | 2.98220941 |
| 119 | regulation of ARF protein signal transduction (GO:0032012) | 2.97854783 |
| 120 | neuromuscular process controlling balance (GO:0050885) | 2.97036553 |
| 121 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.96485206 |
| 122 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.96344314 |
| 123 | presynaptic membrane organization (GO:0097090) | 2.95949512 |
| 124 | myeloid cell activation involved in immune response (GO:0002275) | 2.95726178 |
| 125 | membrane hyperpolarization (GO:0060081) | 2.95676687 |
| 126 | calcium ion-dependent exocytosis (GO:0017156) | 2.95204200 |
| 127 | regulation of neurotransmitter transport (GO:0051588) | 2.94676577 |
| 128 | long-term synaptic potentiation (GO:0060291) | 2.94052426 |
| 129 | establishment of nucleus localization (GO:0040023) | 2.93949449 |
| 130 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.91620888 |
| 131 | behavioral defense response (GO:0002209) | 2.91133716 |
| 132 | behavioral fear response (GO:0001662) | 2.91133716 |
| 133 | pre-miRNA processing (GO:0031054) | 2.90561139 |
| 134 | organelle transport along microtubule (GO:0072384) | 2.90285186 |
| 135 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.88637793 |
| 136 | * regulation of neurotransmitter levels (GO:0001505) | 2.86951529 |
| 137 | cell migration in hindbrain (GO:0021535) | 2.86676734 |
| 138 | histone H3-K9 demethylation (GO:0033169) | 2.85834873 |
| 139 | cell wall macromolecule catabolic process (GO:0016998) | 2.85163550 |
| 140 | prepulse inhibition (GO:0060134) | 2.84564021 |
| 141 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.83999430 |
| 142 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.83910703 |
| 143 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.83125952 |
| 144 | positive T cell selection (GO:0043368) | 2.82766281 |
| 145 | synapse assembly (GO:0007416) | 2.82746848 |
| 146 | intraspecies interaction between organisms (GO:0051703) | 2.81746907 |
| 147 | social behavior (GO:0035176) | 2.81746907 |
| 148 | response to histamine (GO:0034776) | 2.81438010 |
| 149 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.81370018 |
| 150 | negative regulation of B cell mediated immunity (GO:0002713) | 2.81370018 |
| 151 | neuromuscular process controlling posture (GO:0050884) | 2.80481844 |
| 152 | synaptic transmission (GO:0007268) | 2.80140251 |
| 153 | dosage compensation (GO:0007549) | 2.79934761 |
| 154 | learning (GO:0007612) | 2.78879370 |
| 155 | cerebellar granule cell differentiation (GO:0021707) | 2.78738051 |
| 156 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.78628352 |
| 157 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.78561192 |
| 158 | chemosensory behavior (GO:0007635) | 2.77719185 |
| 159 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.77597553 |
| 160 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.77480505 |
| 161 | fear response (GO:0042596) | 2.77420653 |
| 162 | nuclear pore organization (GO:0006999) | 2.77375882 |
| 163 | glycine transport (GO:0015816) | 2.76893077 |
| 164 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.76792021 |
| 165 | positive regulation of neurotransmitter transport (GO:0051590) | 2.76444754 |
| 166 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.74550279 |
| 167 | regulation of mast cell activation (GO:0033003) | 2.73116125 |
| 168 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.69329569 |
| 169 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.69329569 |
| 170 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.69329569 |
| 171 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.67315054 |
| 172 | response to host (GO:0075136) | 2.67315054 |
| 173 | response to host defenses (GO:0052200) | 2.67315054 |
| 174 | histone lysine demethylation (GO:0070076) | 2.66558074 |
| 175 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.64816768 |
| 176 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.63491578 |
| 177 | histone demethylation (GO:0016577) | 2.62978040 |
| 178 | histone mRNA catabolic process (GO:0071044) | 2.61903810 |
| 179 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.61429828 |
| 180 | response to muramyl dipeptide (GO:0032495) | 2.61011631 |
| 181 | negative regulation of B cell proliferation (GO:0030889) | 2.60228718 |
| 182 | granulocyte activation (GO:0036230) | 2.59305241 |
| 183 | regulation of Rap GTPase activity (GO:0032317) | 2.55632784 |
| 184 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.55395814 |
| 185 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.55175495 |
| 186 | nucleobase catabolic process (GO:0046113) | 2.53483982 |
| 187 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.52691647 |
| 188 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.51126301 |
| 189 | response to interleukin-15 (GO:0070672) | 2.51026320 |
| 190 | positive regulation of granulocyte differentiation (GO:0030854) | 2.47282111 |
| 191 | neutrophil chemotaxis (GO:0030593) | 2.46660407 |
| 192 | interferon-gamma production (GO:0032609) | 2.46504531 |
| 193 | pore complex assembly (GO:0046931) | 2.45885197 |
| 194 | histone H3-K4 trimethylation (GO:0080182) | 2.45833455 |
| 195 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.45688028 |
| 196 | peptidyl-lysine trimethylation (GO:0018023) | 2.44847639 |
| 197 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.44067103 |
| 198 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.43787144 |
| 199 | establishment of protein localization to Golgi (GO:0072600) | 2.42548855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.16086617 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.60483760 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.10688233 |
| 4 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.78588236 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.77053341 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.73777977 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.64314071 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.62790889 |
| 9 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.50837451 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.32309920 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.32309920 |
| 12 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.27982913 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.26414412 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24472862 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.22944287 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.21215899 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.16633144 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.16356330 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.16201248 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.15277242 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.13784865 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.09883275 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.09780438 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.09346066 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.07691065 |
| 26 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.96936912 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.95108156 |
| 28 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.94990839 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.93874853 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.92499330 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92189138 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.89615277 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.88120423 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.87561744 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.87471793 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.84055183 |
| 37 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.83723905 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.82195285 |
| 39 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81531627 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.79508865 |
| 41 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78501942 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.75866440 |
| 43 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.65925994 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.65501824 |
| 45 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.64109515 |
| 46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.61584667 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.61551234 |
| 48 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.60719677 |
| 49 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58782631 |
| 50 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.57599599 |
| 51 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.56474197 |
| 52 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.55649624 |
| 53 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55541788 |
| 54 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.54715535 |
| 55 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.54007848 |
| 56 | MYB_26560356_Chip-Seq_TH2_Human | 1.50734291 |
| 57 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48681948 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48203377 |
| 59 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.47777562 |
| 60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45390571 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43757346 |
| 62 | EWS_26573619_Chip-Seq_HEK293_Human | 1.42309433 |
| 63 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42129290 |
| 64 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.42034166 |
| 65 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40242091 |
| 66 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39471445 |
| 67 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.38882316 |
| 68 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38527963 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36490290 |
| 70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36167299 |
| 71 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.36147587 |
| 72 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.35872848 |
| 73 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35617341 |
| 74 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35599002 |
| 75 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.34503423 |
| 76 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.33673334 |
| 77 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31668402 |
| 78 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31490048 |
| 79 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29975528 |
| 80 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.29397093 |
| 81 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.28923741 |
| 82 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28495821 |
| 83 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27742453 |
| 84 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.27403112 |
| 85 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27079417 |
| 86 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.25534518 |
| 87 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.25035991 |
| 88 | AR_19668381_ChIP-Seq_PC3_Human | 1.23228153 |
| 89 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.22266598 |
| 90 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21017137 |
| 91 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.19999944 |
| 92 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19343590 |
| 93 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19269363 |
| 94 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.17981137 |
| 95 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15874780 |
| 96 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.15495149 |
| 97 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15470994 |
| 98 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14943135 |
| 99 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14863487 |
| 100 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.14430858 |
| 101 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.14293819 |
| 102 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.13838360 |
| 103 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.13806975 |
| 104 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11999867 |
| 105 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11957395 |
| 106 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11060093 |
| 107 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.11018809 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11007409 |
| 109 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.10535961 |
| 110 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09635051 |
| 111 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09614604 |
| 112 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.08697426 |
| 113 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.08447928 |
| 114 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08352308 |
| 115 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08277766 |
| 116 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08277766 |
| 117 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.07462667 |
| 118 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07278958 |
| 119 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07073410 |
| 120 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06662715 |
| 121 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06413533 |
| 122 | VDR_22108803_ChIP-Seq_LS180_Human | 1.06071897 |
| 123 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05702347 |
| 124 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05578706 |
| 125 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.05200463 |
| 126 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.04583841 |
| 127 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04508462 |
| 128 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.03765914 |
| 129 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03149238 |
| 130 | MYB_26560356_Chip-Seq_TH1_Human | 1.02947876 |
| 131 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.02582543 |
| 132 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.02429444 |
| 133 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.02373498 |
| 134 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02345289 |
| 135 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02209613 |
| 136 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.01791649 |
| 137 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01648640 |
| 138 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01136284 |
| 139 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01071080 |
| 140 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00333020 |
| 141 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00150574 |
| 142 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00082325 |
| 143 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99849946 |
| 144 | * IGF1R_20145208_ChIP-Seq_DFB_Human | 0.99567237 |
| 145 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99336997 |
| 146 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99265142 |
| 147 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98853837 |
| 148 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98778992 |
| 149 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.98723287 |
| 150 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.97784229 |
| 151 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96917257 |
| 152 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.96869469 |
| 153 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96595332 |
| 154 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.96595332 |
| 155 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95923313 |
| 156 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94829874 |
| 157 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94312647 |
| 158 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.93971625 |
| 159 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93429903 |
| 160 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92670202 |
| 161 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.89621301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.97287679 |
| 2 | MP0003880_abnormal_central_pattern | 4.24818092 |
| 3 | MP0008057_abnormal_DNA_replication | 3.99116790 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.89262780 |
| 5 | MP0004270_analgesia | 3.84907076 |
| 6 | MP0003724_increased_susceptibility_to | 3.65532272 |
| 7 | MP0009046_muscle_twitch | 3.17488179 |
| 8 | MP0009745_abnormal_behavioral_response | 3.14430276 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.10725445 |
| 10 | MP0002009_preneoplasia | 3.08959543 |
| 11 | MP0001968_abnormal_touch/_nociception | 3.01314518 |
| 12 | MP0002064_seizures | 2.88394905 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.78502226 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.67747595 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.63364795 |
| 16 | MP0002272_abnormal_nervous_system | 2.56900182 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.55567080 |
| 18 | MP0001835_abnormal_antigen_presentation | 2.49429031 |
| 19 | MP0003303_peritoneal_inflammation | 2.44399760 |
| 20 | MP0008260_abnormal_autophagy | 2.43061751 |
| 21 | MP0001486_abnormal_startle_reflex | 2.39658460 |
| 22 | MP0003690_abnormal_glial_cell | 2.35996656 |
| 23 | MP0002736_abnormal_nociception_after | 2.27450639 |
| 24 | MP0002822_catalepsy | 2.18990545 |
| 25 | MP0003221_abnormal_cardiomyocyte_apopto | 2.13633673 |
| 26 | MP0001501_abnormal_sleep_pattern | 2.12866888 |
| 27 | MP0001440_abnormal_grooming_behavior | 2.09241162 |
| 28 | MP0003121_genomic_imprinting | 2.05414515 |
| 29 | MP0002733_abnormal_thermal_nociception | 2.03860483 |
| 30 | MP0002067_abnormal_sensory_capabilities | 2.02961881 |
| 31 | MP0001970_abnormal_pain_threshold | 1.99439733 |
| 32 | MP0008569_lethality_at_weaning | 1.87829525 |
| 33 | MP0002184_abnormal_innervation | 1.83683581 |
| 34 | MP0006276_abnormal_autonomic_nervous | 1.82272134 |
| 35 | MP0004924_abnormal_behavior | 1.81645120 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.81645120 |
| 37 | MP0002419_abnormal_innate_immunity | 1.80948045 |
| 38 | MP0000778_abnormal_nervous_system | 1.79904374 |
| 39 | MP0001984_abnormal_olfaction | 1.78956776 |
| 40 | MP0001800_abnormal_humoral_immune | 1.76535769 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.76341502 |
| 42 | MP0003828_pulmonary_edema | 1.76177516 |
| 43 | MP0004811_abnormal_neuron_physiology | 1.73314202 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.69365830 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.68816988 |
| 46 | MP0000569_abnormal_digit_pigmentation | 1.67298236 |
| 47 | MP0003329_amyloid_beta_deposits | 1.66221795 |
| 48 | MP0004858_abnormal_nervous_system | 1.63506200 |
| 49 | MP0002557_abnormal_social/conspecific_i | 1.62995024 |
| 50 | MP0003646_muscle_fatigue | 1.60843514 |
| 51 | MP0000751_myopathy | 1.56667134 |
| 52 | MP0005551_abnormal_eye_electrophysiolog | 1.55942755 |
| 53 | MP0004145_abnormal_muscle_electrophysio | 1.54744372 |
| 54 | MP0003787_abnormal_imprinting | 1.53551096 |
| 55 | MP0000955_abnormal_spinal_cord | 1.51769046 |
| 56 | MP0002420_abnormal_adaptive_immunity | 1.51360861 |
| 57 | MP0001819_abnormal_immune_cell | 1.47899318 |
| 58 | MP0003436_decreased_susceptibility_to | 1.46862523 |
| 59 | MP0005646_abnormal_pituitary_gland | 1.46760463 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.45157395 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.44749762 |
| 62 | * MP0002882_abnormal_neuron_morphology | 1.44675677 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.43596012 |
| 64 | MP0002398_abnormal_bone_marrow | 1.41344184 |
| 65 | MP0004215_abnormal_myocardial_fiber | 1.39948033 |
| 66 | MP0002723_abnormal_immune_serum | 1.38350164 |
| 67 | * MP0002066_abnormal_motor_capabilities/c | 1.35426791 |
| 68 | MP0002452_abnormal_antigen_presenting | 1.34854690 |
| 69 | MP0002166_altered_tumor_susceptibility | 1.34601665 |
| 70 | MP0003879_abnormal_hair_cell | 1.32738014 |
| 71 | MP0003633_abnormal_nervous_system | 1.32721826 |
| 72 | MP0003763_abnormal_thymus_physiology | 1.32625078 |
| 73 | MP0005671_abnormal_response_to | 1.32580181 |
| 74 | MP0001502_abnormal_circadian_rhythm | 1.30218038 |
| 75 | MP0005025_abnormal_response_to | 1.26885266 |
| 76 | MP0006082_CNS_inflammation | 1.25174988 |
| 77 | MP0000703_abnormal_thymus_morphology | 1.24419035 |
| 78 | MP0002396_abnormal_hematopoietic_system | 1.23693485 |
| 79 | MP0005000_abnormal_immune_tolerance | 1.23155097 |
| 80 | MP0005410_abnormal_fertilization | 1.21849283 |
| 81 | MP0000716_abnormal_immune_system | 1.21733332 |
| 82 | MP0009278_abnormal_bone_marrow | 1.20047176 |
| 83 | MP0005645_abnormal_hypothalamus_physiol | 1.18176065 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 1.16869372 |
| 85 | MP0001545_abnormal_hematopoietic_system | 1.16869372 |
| 86 | MP0000689_abnormal_spleen_morphology | 1.16867752 |
| 87 | MP0010386_abnormal_urinary_bladder | 1.16840713 |
| 88 | MP0003631_nervous_system_phenotype | 1.14975042 |
| 89 | MP0001529_abnormal_vocalization | 1.14886517 |
| 90 | * MP0002229_neurodegeneration | 1.14431220 |
| 91 | MP0004885_abnormal_endolymph | 1.14390974 |
| 92 | MP0002722_abnormal_immune_system | 1.13654815 |
| 93 | MP0001905_abnormal_dopamine_level | 1.12368649 |
| 94 | MP0003183_abnormal_peptide_metabolism | 1.11524841 |
| 95 | MP0003890_abnormal_embryonic-extraembry | 1.11290102 |
| 96 | MP0004085_abnormal_heartbeat | 1.09683432 |
| 97 | MP0004484_altered_response_of | 1.06817235 |
| 98 | MP0003300_gastrointestinal_ulcer | 1.06787361 |
| 99 | * MP0002152_abnormal_brain_morphology | 1.05146375 |
| 100 | MP0004142_abnormal_muscle_tone | 1.04603350 |
| 101 | MP0005464_abnormal_platelet_physiology | 1.03797728 |
| 102 | MP0004233_abnormal_muscle_weight | 1.03460592 |
| 103 | MP0001851_eye_inflammation | 1.02761387 |
| 104 | MP0005075_abnormal_melanosome_morpholog | 1.00732922 |
| 105 | MP0005248_abnormal_Harderian_gland | 1.00354318 |
| 106 | MP0009785_altered_susceptibility_to | 0.96839601 |
| 107 | MP0002638_abnormal_pupillary_reflex | 0.96257794 |
| 108 | MP0001188_hyperpigmentation | 0.96133922 |
| 109 | MP0002332_abnormal_exercise_endurance | 0.92548585 |
| 110 | MP0004510_myositis | 0.92217884 |
| 111 | MP0006072_abnormal_retinal_apoptosis | 0.90286764 |
| 112 | MP0002429_abnormal_blood_cell | 0.89526076 |
| 113 | MP0002405_respiratory_system_inflammati | 0.89022233 |
| 114 | MP0004742_abnormal_vestibular_system | 0.86433094 |
| 115 | MP0004036_abnormal_muscle_relaxation | 0.86406211 |
| 116 | * MP0002752_abnormal_somatic_nervous | 0.85774930 |
| 117 | MP0004381_abnormal_hair_follicle | 0.85470916 |
| 118 | MP0005535_abnormal_body_temperature | 0.85103219 |
| 119 | MP0003137_abnormal_impulse_conducting | 0.83883506 |
| 120 | MP0003634_abnormal_glial_cell | 0.83261356 |
| 121 | MP0003632_abnormal_nervous_system | 0.83018848 |
| 122 | MP0002006_tumorigenesis | 0.82351609 |
| 123 | MP0004883_abnormal_blood_vessel | 0.82347842 |
| 124 | MP0008874_decreased_physiological_sensi | 0.81235475 |
| 125 | MP0004130_abnormal_muscle_cell | 0.81224727 |
| 126 | MP0000015_abnormal_ear_pigmentation | 0.79929242 |
| 127 | MP0004808_abnormal_hematopoietic_stem | 0.79002340 |
| 128 | MP0002069_abnormal_eating/drinking_beha | 0.78902718 |
| 129 | MP0005253_abnormal_eye_physiology | 0.78320678 |
| 130 | MP0005620_abnormal_muscle_contractility | 0.77098163 |
| 131 | MP0001790_abnormal_immune_system | 0.76852919 |
| 132 | MP0005387_immune_system_phenotype | 0.76852919 |
| 133 | MP0005310_abnormal_salivary_gland | 0.76781916 |
| 134 | MP0005174_abnormal_tail_pigmentation | 0.76680879 |
| 135 | MP0002133_abnormal_respiratory_system | 0.75393077 |
| 136 | MP0005388_respiratory_system_phenotype | 0.75393077 |
| 137 | MP0001299_abnormal_eye_distance/ | 0.74869589 |
| 138 | MP0008058_abnormal_DNA_repair | 0.74844798 |
| 139 | MP0008961_abnormal_basal_metabolism | 0.74574062 |
| 140 | MP0003122_maternal_imprinting | 0.74369809 |
| 141 | MP0002090_abnormal_vision | 0.74239969 |
| 142 | MP0000920_abnormal_myelination | 0.73975334 |
| 143 | MP0008872_abnormal_physiological_respon | 0.73578410 |
| 144 | MP0003866_abnormal_defecation | 0.73271769 |
| 145 | MP0003567_abnormal_fetal_cardiomyocyte | 0.72985534 |
| 146 | MP0005394_taste/olfaction_phenotype | 0.71887225 |
| 147 | MP0005499_abnormal_olfactory_system | 0.71887225 |
| 148 | MP0000013_abnormal_adipose_tissue | 0.69790132 |
| 149 | MP0001177_atelectasis | 0.69076426 |
| 150 | MP0005187_abnormal_penis_morphology | 0.68896292 |
| 151 | MP0000631_abnormal_neuroendocrine_gland | 0.68269992 |
| 152 | MP0008877_abnormal_DNA_methylation | 0.67555800 |
| 153 | * MP0001963_abnormal_hearing_physiology | 0.66576517 |
| 154 | MP0002972_abnormal_cardiac_muscle | 0.64798844 |
| 155 | MP0000749_muscle_degeneration | 0.64334715 |
| 156 | * MP0003698_abnormal_male_reproductive | 0.63827380 |
| 157 | MP0000604_amyloidosis | 0.63338951 |
| 158 | MP0000747_muscle_weakness | 0.59978336 |
| 159 | MP0003045_fibrosis | 0.58656307 |
| 160 | MP0005409_darkened_coat_color | 0.58449488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.10786556 |
| 2 | Myokymia (HP:0002411) | 5.92450652 |
| 3 | Focal seizures (HP:0007359) | 5.30244151 |
| 4 | Febrile seizures (HP:0002373) | 4.68927210 |
| 5 | Visual hallucinations (HP:0002367) | 4.64448734 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.58697135 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.49991898 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.47986768 |
| 9 | Atonic seizures (HP:0010819) | 4.39666289 |
| 10 | Action tremor (HP:0002345) | 4.06032839 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.00333943 |
| 12 | Absence seizures (HP:0002121) | 3.92596510 |
| 13 | Papillary thyroid carcinoma (HP:0002895) | 3.85152645 |
| 14 | Gaze-evoked nystagmus (HP:0000640) | 3.60715742 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.57695650 |
| 16 | Dialeptic seizures (HP:0011146) | 3.51871238 |
| 17 | Broad-based gait (HP:0002136) | 3.48167304 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.37512768 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 3.30269499 |
| 20 | Truncal ataxia (HP:0002078) | 3.17080512 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.11579035 |
| 22 | Poor eye contact (HP:0000817) | 3.11523460 |
| 23 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.06756670 |
| 24 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.05535186 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 3.03253195 |
| 26 | Optic neuritis (HP:0100653) | 3.03253195 |
| 27 | Hepatoblastoma (HP:0002884) | 2.99625807 |
| 28 | Hyperventilation (HP:0002883) | 2.97644021 |
| 29 | Ankle clonus (HP:0011448) | 2.93198218 |
| 30 | Genetic anticipation (HP:0003743) | 2.92735635 |
| 31 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.92338801 |
| 32 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.91063986 |
| 33 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.91063986 |
| 34 | Hypochromic microcytic anemia (HP:0004840) | 2.90805166 |
| 35 | Dysmetria (HP:0001310) | 2.89207274 |
| 36 | T lymphocytopenia (HP:0005403) | 2.85383897 |
| 37 | Impaired social interactions (HP:0000735) | 2.84604338 |
| 38 | Abnormal social behavior (HP:0012433) | 2.84604338 |
| 39 | Stomatitis (HP:0010280) | 2.84055000 |
| 40 | Depression (HP:0000716) | 2.82498773 |
| 41 | Termporal pattern (HP:0011008) | 2.81192593 |
| 42 | Insidious onset (HP:0003587) | 2.81192593 |
| 43 | Drooling (HP:0002307) | 2.78864690 |
| 44 | Excessive salivation (HP:0003781) | 2.78864690 |
| 45 | Postural instability (HP:0002172) | 2.76731961 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.75419726 |
| 47 | Thyroid carcinoma (HP:0002890) | 2.70396510 |
| 48 | Papilledema (HP:0001085) | 2.68030971 |
| 49 | Progressive inability to walk (HP:0002505) | 2.67364916 |
| 50 | Myositis (HP:0100614) | 2.66992770 |
| 51 | Dysmetric saccades (HP:0000641) | 2.66857106 |
| 52 | Subacute progressive viral hepatitis (HP:0006572) | 2.66746539 |
| 53 | Impaired smooth pursuit (HP:0007772) | 2.64856116 |
| 54 | Mutism (HP:0002300) | 2.62900869 |
| 55 | Amblyopia (HP:0000646) | 2.59632052 |
| 56 | Orchitis (HP:0100796) | 2.58083376 |
| 57 | Scanning speech (HP:0002168) | 2.57275216 |
| 58 | Pheochromocytoma (HP:0002666) | 2.55936570 |
| 59 | Central scotoma (HP:0000603) | 2.55898053 |
| 60 | Abnormality of the lower motor neuron (HP:0002366) | 2.54399942 |
| 61 | Abnormality of T cell number (HP:0011839) | 2.53579892 |
| 62 | Difficulty running (HP:0009046) | 2.53156942 |
| 63 | Recurrent skin infections (HP:0001581) | 2.52890570 |
| 64 | Agnosia (HP:0010524) | 2.52057642 |
| 65 | Volvulus (HP:0002580) | 2.50984738 |
| 66 | Urinary urgency (HP:0000012) | 2.50761762 |
| 67 | Chest pain (HP:0100749) | 2.50535670 |
| 68 | Anxiety (HP:0000739) | 2.49723606 |
| 69 | Medulloblastoma (HP:0002885) | 2.48150784 |
| 70 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.46122275 |
| 71 | Absent/shortened dynein arms (HP:0200106) | 2.46122275 |
| 72 | Abnormality of the corticospinal tract (HP:0002492) | 2.45910689 |
| 73 | Abnormal eating behavior (HP:0100738) | 2.42535296 |
| 74 | Bundle branch block (HP:0011710) | 2.42490598 |
| 75 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.41845304 |
| 76 | Hemiparesis (HP:0001269) | 2.41683970 |
| 77 | Absent speech (HP:0001344) | 2.40867316 |
| 78 | Spastic gait (HP:0002064) | 2.39176825 |
| 79 | Ventricular fibrillation (HP:0001663) | 2.38995350 |
| 80 | Epileptiform EEG discharges (HP:0011182) | 2.38024270 |
| 81 | Abnormality of macrophages (HP:0004311) | 2.37491729 |
| 82 | Recurrent fungal infections (HP:0002841) | 2.37471939 |
| 83 | Keratoconjunctivitis sicca (HP:0001097) | 2.35276336 |
| 84 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.31337558 |
| 85 | Recurrent cutaneous fungal infections (HP:0011370) | 2.31337558 |
| 86 | EEG with generalized epileptiform discharges (HP:0011198) | 2.29879147 |
| 87 | Intention tremor (HP:0002080) | 2.27991017 |
| 88 | Disinhibition (HP:0000734) | 2.25804385 |
| 89 | Encephalitis (HP:0002383) | 2.24014888 |
| 90 | Gastrointestinal infarctions (HP:0005244) | 2.23872717 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.22559749 |
| 92 | Syncope (HP:0001279) | 2.20712815 |
| 93 | Sudden death (HP:0001699) | 2.20514808 |
| 94 | Inability to walk (HP:0002540) | 2.19626921 |
| 95 | Viral hepatitis (HP:0006562) | 2.19160159 |
| 96 | Gingivitis (HP:0000230) | 2.17651975 |
| 97 | Abnormal hair whorl (HP:0010721) | 2.16732622 |
| 98 | Mediastinal lymphadenopathy (HP:0100721) | 2.16400208 |
| 99 | Neuroendocrine neoplasm (HP:0100634) | 2.15056742 |
| 100 | Hypsarrhythmia (HP:0002521) | 2.14520967 |
| 101 | Fetal akinesia sequence (HP:0001989) | 2.14135164 |
| 102 | Prolonged QT interval (HP:0001657) | 2.13697776 |
| 103 | Lower limb muscle weakness (HP:0007340) | 2.13138231 |
| 104 | Spontaneous hematomas (HP:0007420) | 2.11647038 |
| 105 | Amaurosis fugax (HP:0100576) | 2.11395615 |
| 106 | Stomach cancer (HP:0012126) | 2.10736167 |
| 107 | Bradykinesia (HP:0002067) | 2.10599378 |
| 108 | IgM deficiency (HP:0002850) | 2.10045926 |
| 109 | Stereotypic behavior (HP:0000733) | 2.10034930 |
| 110 | Abnormality of binocular vision (HP:0011514) | 2.08209346 |
| 111 | Diplopia (HP:0000651) | 2.08209346 |
| 112 | Abnormal EKG (HP:0003115) | 2.07948277 |
| 113 | Obstructive lung disease (HP:0006536) | 2.07810281 |
| 114 | Chronic obstructive pulmonary disease (HP:0006510) | 2.07810281 |
| 115 | Limb dystonia (HP:0002451) | 2.06391940 |
| 116 | Impaired vibratory sensation (HP:0002495) | 2.06216499 |
| 117 | Leukocytosis (HP:0001974) | 2.06152998 |
| 118 | Pelvic girdle muscle weakness (HP:0003749) | 2.05879520 |
| 119 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.05505806 |
| 120 | Cerebral inclusion bodies (HP:0100314) | 2.05424378 |
| 121 | Neurofibrillary tangles (HP:0002185) | 2.04440653 |
| 122 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.03478014 |
| 123 | Abnormality of macular pigmentation (HP:0008002) | 2.00655128 |
| 124 | Meningitis (HP:0001287) | 2.00638912 |
| 125 | Torticollis (HP:0000473) | 1.98901615 |
| 126 | Arterial thrombosis (HP:0004420) | 1.97773060 |
| 127 | Inappropriate behavior (HP:0000719) | 1.96928770 |
| 128 | Amyotrophic lateral sclerosis (HP:0007354) | 1.96033591 |
| 129 | Hemiplegia (HP:0002301) | 1.94310714 |
| 130 | Bladder neoplasm (HP:0009725) | 1.94304068 |
| 131 | Bladder carcinoma (HP:0002862) | 1.94304068 |
| 132 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.93450553 |
| 133 | Megalencephaly (HP:0001355) | 1.93386709 |
| 134 | Gait ataxia (HP:0002066) | 1.92874649 |
| 135 | Agitation (HP:0000713) | 1.92573660 |
| 136 | Gingival bleeding (HP:0000225) | 1.92268808 |
| 137 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.90924199 |
| 138 | Subaortic stenosis (HP:0001682) | 1.90924199 |
| 139 | Hypoplasia of the brainstem (HP:0002365) | 1.88291181 |
| 140 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.88291181 |
| 141 | Status epilepticus (HP:0002133) | 1.87362572 |
| 142 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.87151458 |
| 143 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.87114944 |
| 144 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.87114944 |
| 145 | Abnormality of saccadic eye movements (HP:0000570) | 1.86491890 |
| 146 | Gait imbalance (HP:0002141) | 1.86403412 |
| 147 | Protruding tongue (HP:0010808) | 1.85815424 |
| 148 | Slow saccadic eye movements (HP:0000514) | 1.85210618 |
| 149 | Atrial fibrillation (HP:0005110) | 1.85202840 |
| 150 | Primary atrial arrhythmia (HP:0001692) | 1.84676715 |
| 151 | Abnormality of salivation (HP:0100755) | 1.83912855 |
| 152 | Truncal obesity (HP:0001956) | 1.82879561 |
| 153 | Aqueductal stenosis (HP:0002410) | 1.82050527 |
| 154 | Exercise-induced myalgia (HP:0003738) | 1.81686902 |
| 155 | Thyroiditis (HP:0100646) | 1.80661775 |
| 156 | Blue irides (HP:0000635) | 1.80457891 |
| 157 | Large earlobe (HP:0009748) | 1.79488451 |
| 158 | Generalized myoclonic seizures (HP:0002123) | 1.79158763 |
| 159 | Focal dystonia (HP:0004373) | 1.77771980 |
| 160 | Congenital stationary night blindness (HP:0007642) | 1.77581506 |
| 161 | Spastic paraplegia (HP:0001258) | 1.77516947 |
| 162 | Polyphagia (HP:0002591) | 1.77381402 |
| 163 | Rhabdomyosarcoma (HP:0002859) | 1.77232996 |
| 164 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.74916419 |
| 165 | Dyschromatopsia (HP:0007641) | 1.74718200 |
| 166 | Pulmonary embolism (HP:0002204) | 1.72186684 |
| 167 | Prolonged bleeding time (HP:0003010) | 1.72073894 |
| 168 | Resting tremor (HP:0002322) | 1.69304888 |
| 169 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.67793314 |
| 170 | Colitis (HP:0002583) | 1.67395284 |
| 171 | Urticaria (HP:0001025) | 1.67018757 |
| 172 | Inflammation of the large intestine (HP:0002037) | 1.64981709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.32002348 |
| 2 | MAP3K9 | 3.66568186 |
| 3 | EPHA4 | 3.48573477 |
| 4 | MAP3K4 | 3.27771848 |
| 5 | MARK1 | 3.18387048 |
| 6 | MAP2K7 | 2.68833094 |
| 7 | MINK1 | 2.56882702 |
| 8 | PAK6 | 2.22588443 |
| 9 | BLK | 2.21633133 |
| 10 | KSR2 | 2.12884802 |
| 11 | PRKD3 | 2.09118228 |
| 12 | MAP2K4 | 2.08724680 |
| 13 | NTRK2 | 1.95315025 |
| 14 | DAPK2 | 1.94355996 |
| 15 | FGR | 1.92882406 |
| 16 | RIPK4 | 1.89500704 |
| 17 | NTRK1 | 1.79231752 |
| 18 | YES1 | 1.70692041 |
| 19 | CAMKK1 | 1.69848237 |
| 20 | PNCK | 1.65713924 |
| 21 | CSK | 1.62925953 |
| 22 | MAP3K12 | 1.61730667 |
| 23 | TEC | 1.57877288 |
| 24 | MAP2K3 | 1.55894520 |
| 25 | BCR | 1.54808901 |
| 26 | KSR1 | 1.53046824 |
| 27 | PHKG2 | 1.52705176 |
| 28 | PHKG1 | 1.52705176 |
| 29 | STK38 | 1.51041333 |
| 30 | ERBB3 | 1.50292640 |
| 31 | CASK | 1.47343726 |
| 32 | CDK5 | 1.43809632 |
| 33 | BTK | 1.43708512 |
| 34 | MAPK13 | 1.40935208 |
| 35 | IRAK4 | 1.37007381 |
| 36 | CAMKK2 | 1.35234508 |
| 37 | BRD4 | 1.33619371 |
| 38 | SYK | 1.31151586 |
| 39 | PLK2 | 1.30892729 |
| 40 | TNIK | 1.23925332 |
| 41 | GRK5 | 1.22776870 |
| 42 | JAK2 | 1.22270736 |
| 43 | PDK4 | 1.20562551 |
| 44 | PDK3 | 1.20562551 |
| 45 | GRK6 | 1.19139456 |
| 46 | MAP3K2 | 1.19084533 |
| 47 | IRAK2 | 1.17484466 |
| 48 | HCK | 1.17030806 |
| 49 | SIK2 | 1.16595490 |
| 50 | EPHA3 | 1.15954582 |
| 51 | PINK1 | 1.12443157 |
| 52 | TYK2 | 1.11813224 |
| 53 | DYRK3 | 1.10706100 |
| 54 | DAPK1 | 1.09874565 |
| 55 | DYRK1B | 1.07648928 |
| 56 | PRKCG | 1.07488674 |
| 57 | MAP3K10 | 1.07276799 |
| 58 | ACVR1B | 1.06651034 |
| 59 | SIK3 | 1.05875024 |
| 60 | CAMK2A | 1.05869024 |
| 61 | RET | 1.05252852 |
| 62 | FRK | 1.05199251 |
| 63 | RPS6KA4 | 1.05132627 |
| 64 | LMTK2 | 1.04987705 |
| 65 | SGK223 | 1.04092248 |
| 66 | SGK494 | 1.04092248 |
| 67 | LATS2 | 1.03415257 |
| 68 | ARAF | 1.03233130 |
| 69 | MAP3K13 | 1.01248261 |
| 70 | SGK2 | 0.99319335 |
| 71 | MARK3 | 0.99014477 |
| 72 | WNK1 | 0.97301902 |
| 73 | CAMK1G | 0.96417962 |
| 74 | PRPF4B | 0.96238028 |
| 75 | SRPK1 | 0.93637791 |
| 76 | MAP3K6 | 0.91516824 |
| 77 | FES | 0.91109308 |
| 78 | TAOK1 | 0.90627837 |
| 79 | LYN | 0.90050518 |
| 80 | ZAP70 | 0.90016379 |
| 81 | ITK | 0.89658544 |
| 82 | IRAK1 | 0.87406752 |
| 83 | PAK3 | 0.86930469 |
| 84 | PTK2B | 0.86795287 |
| 85 | CAMK1 | 0.86670660 |
| 86 | STK11 | 0.86563123 |
| 87 | UHMK1 | 0.86107801 |
| 88 | MAP4K1 | 0.85208003 |
| 89 | SGK3 | 0.84281010 |
| 90 | MAP3K5 | 0.83603622 |
| 91 | PRKCH | 0.82973216 |
| 92 | TXK | 0.82446801 |
| 93 | TRIM28 | 0.81485712 |
| 94 | RIPK1 | 0.81357541 |
| 95 | CDK19 | 0.80921408 |
| 96 | TYRO3 | 0.79848548 |
| 97 | CDK6 | 0.79205367 |
| 98 | RAF1 | 0.79072828 |
| 99 | SGK1 | 0.78251900 |
| 100 | PDK1 | 0.76531570 |
| 101 | IKBKE | 0.74612029 |
| 102 | CAMK1D | 0.74546988 |
| 103 | LCK | 0.74440105 |
| 104 | DMPK | 0.73780129 |
| 105 | CDK18 | 0.72240306 |
| 106 | BMPR2 | 0.70982712 |
| 107 | CDK15 | 0.70454606 |
| 108 | CAMK2B | 0.70037500 |
| 109 | PIM1 | 0.69633908 |
| 110 | MARK2 | 0.69461127 |
| 111 | PIK3CG | 0.69144790 |
| 112 | CSNK1G2 | 0.68867941 |
| 113 | CDK14 | 0.68180298 |
| 114 | JAK1 | 0.68121255 |
| 115 | PDPK1 | 0.67021568 |
| 116 | CSF1R | 0.64782141 |
| 117 | MAP3K1 | 0.64499229 |
| 118 | CAMK2D | 0.64441051 |
| 119 | DYRK1A | 0.64130352 |
| 120 | OBSCN | 0.63923490 |
| 121 | MUSK | 0.62389167 |
| 122 | MKNK1 | 0.61516455 |
| 123 | TAOK3 | 0.61501147 |
| 124 | STK39 | 0.60909550 |
| 125 | OXSR1 | 0.60562450 |
| 126 | EGFR | 0.60271125 |
| 127 | ERBB2 | 0.58505195 |
| 128 | CDK11A | 0.57623185 |
| 129 | STK4 | 0.56905717 |
| 130 | MKNK2 | 0.56815707 |
| 131 | TNK2 | 0.56374744 |
| 132 | JAK3 | 0.56206700 |
| 133 | PRKCE | 0.55702928 |
| 134 | WNK4 | 0.55427597 |
| 135 | STK38L | 0.55143863 |
| 136 | MAP3K14 | 0.54500885 |
| 137 | PDK2 | 0.51742719 |
| 138 | RPS6KA3 | 0.50962648 |
| 139 | CDC42BPA | 0.48638610 |
| 140 | PRKCZ | 0.46851258 |
| 141 | CCNB1 | 0.46252284 |
| 142 | MAPK10 | 0.44580353 |
| 143 | ICK | 0.42664034 |
| 144 | CAMK4 | 0.41060521 |
| 145 | CAMK2G | 0.40976324 |
| 146 | MAPK12 | 0.39925183 |
| 147 | ALK | 0.39092672 |
| 148 | PKN1 | 0.38657169 |
| 149 | FYN | 0.38457605 |
| 150 | FER | 0.37879122 |
| 151 | WNK3 | 0.36699377 |
| 152 | FGFR2 | 0.36016211 |
| 153 | PRKAA1 | 0.34840095 |
| 154 | RPS6KA2 | 0.34443489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.34603144 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.93191701 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.60164449 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.59169885 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.59117691 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.53771651 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.48678972 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.44132502 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.33904825 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.25176532 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.12573753 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.11212382 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.05002070 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.03440842 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.96568831 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.95055658 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.92987755 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.88290485 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.82309555 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.81769243 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.77978488 |
| 22 | Phototransduction_Homo sapiens_hsa04744 | 1.76375048 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.75686541 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74812492 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74517594 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.73372061 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.67021099 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63974833 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.63671961 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.59550248 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.58678230 |
| 32 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.55960699 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.45634429 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.45306761 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.44295995 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.41680977 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.39796437 |
| 38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.37340505 |
| 39 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.33458432 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.31086775 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.30907268 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.30565654 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29010737 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26923695 |
| 45 | Gap junction_Homo sapiens_hsa04540 | 1.25832832 |
| 46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.23717978 |
| 47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.19682778 |
| 48 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.19237829 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.16194579 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14508669 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.11911003 |
| 52 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.11158966 |
| 53 | Glioma_Homo sapiens_hsa05214 | 1.09866609 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07507020 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07403214 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.06605349 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04485177 |
| 58 | Measles_Homo sapiens_hsa05162 | 1.03703378 |
| 59 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03123084 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.02891541 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 1.01990340 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00646900 |
| 63 | Axon guidance_Homo sapiens_hsa04360 | 1.00608386 |
| 64 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00551208 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00515231 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99367948 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94530421 |
| 68 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.93379086 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.92077037 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 0.91495695 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.91214840 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 0.91205689 |
| 73 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.91111426 |
| 74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90711533 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89089065 |
| 76 | Melanogenesis_Homo sapiens_hsa04916 | 0.88738119 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87320092 |
| 78 | Salmonella infection_Homo sapiens_hsa05132 | 0.86187884 |
| 79 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84478717 |
| 80 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83833123 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82808021 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81207302 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.81191470 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.79451252 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79258540 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78562929 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78325260 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76097513 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76021312 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75669867 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74521770 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73712302 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.71914700 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70244525 |
| 95 | Malaria_Homo sapiens_hsa05144 | 0.70083959 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69799906 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68350024 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68336532 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66961394 |
| 100 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.66492317 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66324813 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65874271 |
| 103 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.65709345 |
| 104 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.65641118 |
| 105 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64236178 |
| 106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.63294056 |
| 107 | Allograft rejection_Homo sapiens_hsa05330 | 0.62653239 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61754834 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61727559 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.61693820 |
| 111 | Apoptosis_Homo sapiens_hsa04210 | 0.61057420 |
| 112 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.60115046 |
| 113 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.59282283 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58161549 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57673239 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56838792 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55411793 |
| 118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54788692 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54223239 |
| 120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.52225548 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51336729 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50214466 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49352796 |
| 124 | Alcoholism_Homo sapiens_hsa05034 | 0.48058311 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.47488158 |
| 126 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.44706006 |
| 127 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44300875 |
| 128 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42102566 |
| 129 | Alzheimers disease_Homo sapiens_hsa05010 | 0.40526843 |
| 130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39242712 |
| 131 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39115313 |
| 132 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36752609 |
| 133 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35691697 |
| 134 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.34875568 |
| 135 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32903231 |
| 136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30328850 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30133064 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29705060 |
| 139 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.28177859 |
| 140 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27288587 |
| 141 | Bile secretion_Homo sapiens_hsa04976 | 0.27151541 |
| 142 | Platelet activation_Homo sapiens_hsa04611 | 0.25530545 |
| 143 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25202525 |
| 144 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25031395 |

